Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Stroke

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 132 articles:
HTML format
Text format



Single Articles


    September 2017
  1. SAMBOLA A, Ruiz-Meana M, Barba I, Del Blanco BG, et al
    Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction.
    Int J Cardiol. 2017;243:9-14.
    PubMed     Text format     Abstract available


  2. TOCCI G, Presta V
    Increased arterial stiffness and haemorrhagic transformation in ischaemic stroke after thrombolysis: A new marker of risk for cerebrovascular events and complications.
    Int J Cardiol. 2017;243:471-472.
    PubMed     Text format    


  3. ACAMPA M, Camarri S, Lazzerini PE, Guideri F, et al
    Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis.
    Int J Cardiol. 2017;243:466-470.
    PubMed     Text format     Abstract available


    July 2017
  4. ROSSELLO X, Huo Y, Pocock S, de Werf FV, et al
    Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality.
    Int J Cardiol. 2017 Jul 15. pii: S0167-5273(17)32845.
    PubMed     Text format     Abstract available


    June 2017
  5. LAVI S, Iqbal J, Cairns JA, Cantor WJ, et al
    Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial.
    Int J Cardiol. 2017 Jun 29. pii: S0167-5273(17)33508.
    PubMed     Text format     Abstract available


  6. VIDALE S, Arnaboldi M, Bosio V, Corrado G, et al
    Short-term air pollution exposure and cardiovascular events: A 10-year study in the urban area of Como, Italy.
    Int J Cardiol. 2017 Jun 15. pii: S0167-5273(17)31683.
    PubMed     Text format     Abstract available


  7. CAPPELLARI M, Bovi P
    Direct oral anticoagulants in patients with cervical artery dissection and cerebral venous thrombosis. A case series and review of the literature.
    Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32629.
    PubMed     Text format     Abstract available


    May 2017
  8. MATUSIK PT, Matusik PS, Kornacewicz-Jach Z, Malecka B, et al
    Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
    Int J Cardiol. 2017 May 16. pii: S0167-5273(17)31785.
    PubMed     Text format     Abstract available


  9. BECATTINI C, Franco L, Agnelli G
    Risk of death in patients with major bleedings while on treatment with oral anticoagulants.
    Int J Cardiol. 2017;235:200.
    PubMed     Text format    


  10. ALEXOPOULOS D
    Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
    Int J Cardiol. 2017;234:131.
    PubMed     Text format    


    February 2017
  11. GUIMARAES LF, Stone GW, Caixeta A
    Reply: Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
    Int J Cardiol. 2017 Feb 11. pii: S0167-5273(17)30775.
    PubMed     Text format    


    January 2017
  12. VEDOVATI MC, Verdecchia P, Giustozzi M, Molini G, et al
    Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)34180.
    PubMed     Text format     Abstract available


  13. KO D, Thigpen JL, Otis JA, Forster K, et al
    Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.
    Int J Cardiol. 2017;227:808-812.
    PubMed     Text format     Abstract available


    December 2016
  14. GUIMARAES LF, Genereux P, Silveira D, Pesaro AE, et al
    P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial.
    Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34824.
    PubMed     Text format     Abstract available


    November 2016
  15. WYBRANIEC MT, Faryan M, Kusz B, Lasek-Bal A, et al
    CHA2DS2-VASC-AF2 score accurately predicts moderate-to-severe acute neurological dysfunction in the course of first ever ischaemic stroke.
    Int J Cardiol. 2016;228:286-288.
    PubMed     Text format    


  16. WONG CK
    Simplifying electrocardiographic assessment in STEMI reperfusion management: Pros and cons.
    Int J Cardiol. 2016;227:30-36.
    PubMed     Text format     Abstract available


  17. SASAI M, Iso Y, Mizukami T, Tomosugi N, et al
    Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human.
    Int J Cardiol. 2016;227:114-121.
    PubMed     Text format     Abstract available


  18. BECATTINI C, Franco L, Beyer-Westendorf J, Masotti L, et al
    Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
    Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33576.
    PubMed     Text format     Abstract available


  19. ZHOU X, Cao K, Kou S, Qu S, et al
    Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.
    Int J Cardiol. 2016;228:906-911.
    PubMed     Text format     Abstract available


    October 2016
  20. NAVARESE EP, Kolodziejczak M, Winter MP, Alimohammad A, et al
    Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.
    Int J Cardiol. 2016 Oct 29. pii: S0167-5273(16)33272.
    PubMed     Text format     Abstract available


    September 2016
  21. AKCAY M, Soylu K, Yanik A
    Acute thrombotic left main coronary artery; treatment with low dose slow infusion tPA.
    Int J Cardiol. 2016;224:265-266.
    PubMed     Text format    


  22. TAKEUCHI D, Inai K, Shinohara T, Nakanishi T, et al
    Blood coagulation abnormalities and the usefulness of D-dimer level for detecting intracardiac thrombosis in adult Fontan patients.
    Int J Cardiol. 2016;224:139-144.
    PubMed     Text format     Abstract available


    July 2016
  23. SENOO K, Lip GY
    Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
    Int J Cardiol. 2016;221:379-382.
    PubMed     Text format     Abstract available


    June 2016
  24. PAGNESI M, Martino EA, Chiarito M, Mangieri A, et al
    Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis.
    Int J Cardiol. 2016;221:97-106.
    PubMed     Text format     Abstract available


  25. CHOI EJ, Lee IH, Je NK
    Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era.
    Int J Cardiol. 2016;220:647-652.
    PubMed     Text format     Abstract available


  26. PALOMAKI A, Kiviniemi T, Mustonen P, Odei C, et al
    Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.
    Int J Cardiol. 2016 Jun 23. pii: S0167-5273(16)31117.
    PubMed     Text format     Abstract available


  27. XIA SJ, Du X, Li C, Wu JH, et al
    Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
    Int J Cardiol. 2016;220:284-289.
    PubMed     Text format     Abstract available


  28. ROKOS J, Heger M, Stollberger C, Finsterer J, et al
    Bipolar disorder, ischemic stroke, mitral valve vegetation and recurrent venous thrombosis due to antiphospholipid syndrome despite rivaroxaban.
    Int J Cardiol. 2016;221:383-384.
    PubMed     Text format    


  29. RICCI RP, Vaccari D, Morichelli L, Zanotto G, et al
    Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Int J Cardiol. 2016;219:251-256.
    PubMed     Text format     Abstract available


  30. COLANTONIO LD, Gamboa CM, Kleindorfer DO, Carson AP, et al
    Stroke symptoms and risk for incident coronary heart disease in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Int J Cardiol. 2016;220:122-128.
    PubMed     Text format     Abstract available


    May 2016
  31. TONG Y, Cai L, Zhang YW, Lin L, et al
    Role of functional polymorphisms of the IL-10 gene promoter in the risk of ischemic stroke in Chinese Uyghur population: One case-control study.
    Int J Cardiol. 2016;211:58-60.
    PubMed     Text format    


    April 2016
  32. RICCI F, Di Castelnuovo A, Savarese G, Perrone Filardi P, et al
    ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.
    Int J Cardiol. 2016;217:128-134.
    PubMed     Text format     Abstract available


  33. STOLLBERGER C, Finsterer J, Schneider B
    Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure?
    Int J Cardiol. 2016;216:186-187.
    PubMed     Text format    


  34. ALBERTS MJ, Peacock WF, Fields LE, Bunz TJ, et al
    Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.
    Int J Cardiol. 2016;215:11-13.
    PubMed     Text format    


  35. XIE XX, Liu P, Wan FY, Lin SG, et al
    Blood pressure lowering and stroke events in type 2 diabetes: A network meta-analysis of randomized controlled trials.
    Int J Cardiol. 2016;208:141-6.
    PubMed     Text format    


    March 2016
  36. KOUNIS NG, Grapsas N, Soufras GD, Lianas D, et al
    Clinical and subclinical leaflet thrombosis in bioprosthetic aortic valves: A manifestation of Kounis syndrome?
    Int J Cardiol. 2016;214:86-87.
    PubMed     Text format    


  37. EFTEKHARI A, Damgaard D, Grove EL
    Fatal stroke following treatment with apixaban in a patient with atrial fibrillation and left atrial appendage thrombus.
    Int J Cardiol. 2016;214:131-132.
    PubMed     Text format    


  38. WATANABE E, Yamamoto M, Kodama I, Inoue H, et al
    Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.
    Int J Cardiol. 2016;212:311-317.
    PubMed     Text format     Abstract available


  39. COLEMAN CI, Tangirala M, Evers T
    Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States.
    Int J Cardiol. 2016;212:171-173.
    PubMed     Text format    


  40. TONG Y, Huang X, Wang Z, Han S, et al
    Effects of functional genetic variants in PPARdelta encoding peroxisome proliferator-activated receptor delta on the risk of ischemic stroke in Chinese Han population.
    Int J Cardiol. 2016;207:297-9.
    PubMed     Text format    


  41. DELLBORG M, Eriksson P
    Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke - Effect of lost-to-follow-up and withdrawal of consent.
    Int J Cardiol. 2016;207:308-9.
    PubMed     Text format    


    February 2016
  42. YIP HK, Yuen CM, Chen KH, Chai HT, et al
    Tissue plasminogen activator deficiency preserves neurological function and protects against murine acute ischemic stroke.
    Int J Cardiol. 2016;205:133-41.
    PubMed     Text format     Abstract available


  43. SEO WK, Kang SH, Jung JM, Choi JY, et al
    Novel composite score to predict atrial Fibrillation in acute stroke patients: AF predicting score in acute stroke.
    Int J Cardiol. 2016;209:184-189.
    PubMed     Text format     Abstract available


  44. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
    Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
    Int J Cardiol. 2016;209:1-6.
    PubMed     Text format     Abstract available


  45. LEE YB, Jeong SW, Rhee MY, Leem CH, et al
    Aorta-to-arm pulse wave transit time ratio: Better prediction of coronary artery disease and stroke than pulse wave velocity.
    Int J Cardiol. 2016;204:1-3.
    PubMed     Text format    


    January 2016
  46. CHHABRA L
    Importance of P-wave indices in stroke.
    Int J Cardiol. 2016;203:962-3.
    PubMed     Text format    


  47. LEE YJ, Park JK, Uhm JS, Kim JY, et al
    Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.
    Int J Cardiol. 2016;203:372-8.
    PubMed     Text format     Abstract available


  48. KEFER J, Tzikas A, Freixa X, Shakir S, et al
    Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Int J Cardiol. 2016;207:335-340.
    PubMed     Text format     Abstract available


  49. PANG J, Zhang Z, Zheng TZ, Bassig BA, et al
    Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis.
    Int J Cardiol. 2016;202:967-74.
    PubMed     Text format     Abstract available


  50. MAR PL, Familtsev D, Ezekowitz MD, Lakkireddy D, et al
    Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
    Int J Cardiol. 2016;202:578-85.
    PubMed     Text format     Abstract available


    December 2015
  51. CHEN YL, Tsai TH, Wallace CG, Chen YL, et al
    Intra-carotid arterial administration of autologous peripheral blood-derived endothelial progenitor cells improves acute ischemic stroke neurological outcomes in rats.
    Int J Cardiol. 2015;201:668-83.
    PubMed     Text format     Abstract available


  52. KANAI M, Kubo H, Kitamura Y, Izawa KP, et al
    Difference in autonomic nervous activity in different subtypes of noncardioembolic ischemic stroke.
    Int J Cardiol. 2015;201:171-3.
    PubMed     Text format    


  53. GUO X, Li Z, Sun G, Guo L, et al
    Comparison of four nontraditional lipid profiles in relation to ischemic stroke among hypertensive Chinese population.
    Int J Cardiol. 2015;201:123-5.
    PubMed     Text format    


  54. TIAN L, Qiu H, Pun VC, Ho KF, et al
    Carbon monoxide and stroke: A time series study of ambient air pollution and emergency hospitalizations.
    Int J Cardiol. 2015;201:4-9.
    PubMed     Text format     Abstract available


    November 2015
  55. GARG J, Chaudhary R, Krishnamoorthy P, Shah N, et al
    Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients.
    Int J Cardiol. 2015;203:906-908.
    PubMed     Text format    


  56. MEYER ML, Jaensch A, Mons U, Breitling LP, et al
    Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram.
    Int J Cardiol. 2015;203:1014-1015.
    PubMed     Text format    


  57. KONNO S, Munakata M
    High-density lipoprotein cholesterol might be a better predictor of stroke than other lipid measures in the general Japanese population: The Watari study.
    Int J Cardiol. 2015;203:874-876.
    PubMed     Text format    


  58. MARCUCCI M, Skjoth F, Lip GY, Iorio A, et al
    A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation.
    Int J Cardiol. 2015;203:785-790.
    PubMed     Text format     Abstract available


  59. YANG Y, Liu Q, Wu Z, Li X, et al
    Is hyperuricemia a recognizable biomarker for low risk of stroke in patients with atrial fibrillation?
    Int J Cardiol. 2015;203:624-625.
    PubMed     Text format    


  60. PIRINEN J, Putaala J, Aro AL, Surakka I, et al
    Resting 12-lead electrocardiogram reveals high-risk sources of cardioembolism in young adult ischemic stroke.
    Int J Cardiol. 2015;198:196-200.
    PubMed     Text format     Abstract available


    October 2015
  61. EYUBOGLU M
    Inadequate anticoagulation by Vitamin K antagonists and major adverse cardiovascular events other than stroke.
    Int J Cardiol. 2015 Oct 30. pii: S0167-5273(15)30553.
    PubMed     Text format    


  62. PALOMAKI A, Mustonen P, Hartikainen JE, Nuotio I, et al
    Strokes after cardioversion of atrial fibrillation - The FibStroke study.
    Int J Cardiol. 2015;203:269-273.
    PubMed     Text format    


  63. GARGIULO G, Capodanno D, Sannino A, Barbanti M, et al
    New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association?
    Int J Cardiol. 2015;203:264-266.
    PubMed     Text format    


  64. LIN YS, Tung TH, Wang J, Chen YF, et al
    Peripheral arterial disease and atrial fibrillation and risk of stroke, heart failure hospitalization and cardiovascular death: A nationwide cohort study.
    Int J Cardiol. 2015;203:204-211.
    PubMed     Text format     Abstract available


  65. PASTORI D, Pignatelli P, Saliola M, Carnevale R, et al
    Reply to: "Inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke".
    Int J Cardiol. 2015 Oct 17. pii: S0167-5273(15)30687.
    PubMed     Text format    


  66. ZHOU X, Zhang W, Lv W, Zhou Q, et al
    Left atrial appendage occlusion in atrial fibrillation for stroke prevention: A systemic review.
    Int J Cardiol. 2015;203:55-59.
    PubMed     Text format     Abstract available


  67. HUANG H, Zeng J, Kang Y, Huang H, et al
    Acute ischemia stroke: A rare and severe complication of ovarian hyperstimulation syndrome.
    Int J Cardiol. 2015;203:418-419.
    PubMed     Text format    


  68. BAIN LK, Myint PK, Jennings A, Lentjes MA, et al
    The relationship between dietary magnesium intake, stroke and its major risk factors, blood pressure and cholesterol, in the EPIC-Norfolk cohort.
    Int J Cardiol. 2015;196:108-14.
    PubMed     Text format     Abstract available


    September 2015
  69. ERGELEN M, Uyarel H, Goktekin O
    Interventional cardiologists in the treatment of acute ischemic stroke: New players in the game.
    Int J Cardiol. 2015;202:674-675.
    PubMed     Text format    


  70. KIM H, Ryu DR
    Difference in stroke incidence between Korean and Japanese patients initiating dialysis - era or ethnic effect?
    Int J Cardiol. 2015 Sep 25. pii: S0167-5273(15)30397.
    PubMed     Text format    


  71. NOZOE M, Kitamura Y, Kanai M, Kubo H, et al
    Physical activity in acute ischemic stroke patients during hospitalization.
    Int J Cardiol. 2015;202:624-626.
    PubMed     Text format    


  72. KAWADA T
    Risk of major cardiovascular events in patients with hemodialysis or peritoneal dialysis with special reference to stroke.
    Int J Cardiol. 2015 Sep 25. pii: S0167-5273(15)30302.
    PubMed     Text format    


  73. COLEMAN CI, Antz M, Ehlken B, Evers T, et al
    REal-LIfe Evidence of stroke prevention in patients with atrial Fibrillation - The RELIEF study.
    Int J Cardiol. 2015;203:882-884.
    PubMed     Text format    


  74. DURHEIM MT, Cyr DD, Lopes RD, Thomas LE, et al
    Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.
    Int J Cardiol. 2015;202:589-594.
    PubMed     Text format     Abstract available


  75. MIRZADA N, Ladenvall P, Hansson PO, Eriksson P, et al
    Recurrent stroke in patients with patent foramen ovale: An observational prospective study of percutaneous closure of PFO versus non-closure.
    Int J Cardiol. 2015;195:293-9.
    PubMed     Text format     Abstract available


  76. KUMAR N, Venkatraman A, Garg N
    Seasonality in acute ischemic stroke related hospitalizations and case fatality rate in the United States.
    Int J Cardiol. 2015;195:134-5.
    PubMed     Text format    


  77. AHMAD Y, Nijjer S, Cook CM, El-Harasis M, et al
    A new method of applying randomised control study data to the individual patient: A novel quantitative patient-centred approach to interpreting composite end points.
    Int J Cardiol. 2015;195:216-24.
    PubMed     Text format     Abstract available


    August 2015
  78. YUAN M, Zhou HY, Xiao XL, Wang ZQ, et al
    Inflammatory bowel disease and risk of stroke: A meta-analysis of cohort studies.
    Int J Cardiol. 2015;202:106-109.
    PubMed     Text format    


  79. BLANN AD, Banerjee A, Lane DA, Torp-Pedersen C, et al
    Net clinical benefit of edoxaban versus no treatment in a 'real world' atrial fibrillation population: A modelling analysis based on a nationwide cohort study.
    Int J Cardiol. 2015;201:693-698.
    PubMed     Text format     Abstract available


  80. PASTORI D, Pignatelli P, Saliola M, Carnevale R, et al
    Inadequate anticoagulation by Vitamin K Antagonists is associated with Major Adverse Cardiovascular Events in patients with atrial fibrillation.
    Int J Cardiol. 2015;201:513-516.
    PubMed     Text format     Abstract available


  81. PENG H, Chen M, Li G, Zhang M, et al
    Combination refusion therapy for a hemodynamically unstable patient with acute myocardial infarction complicated by acute ischemic stroke within a time window.
    Int J Cardiol. 2015;201:152-153.
    PubMed     Text format    


  82. CHENG CL, Chien HC, Lee CH, Lin SJ, et al
    Validity of in-hospital mortality data among patients with acute myocardial infarction or stroke in National Health Insurance Research Database in Taiwan.
    Int J Cardiol. 2015;201:96-101.
    PubMed     Text format     Abstract available


    July 2015
  83. BATUROVA MA, Lindgren A, Carlson J, Shubik YV, et al
    Predictors of new onset atrial fibrillation during 10-year follow-up after first-ever ischemic stroke.
    Int J Cardiol. 2015;199:248-252.
    PubMed     Text format     Abstract available


  84. XU T, Ke K
    C-reactive protein and ischemic stroke risk in general population: A dose-response meta-analysis of prospective studies.
    Int J Cardiol. 2015;190:264-7.
    PubMed     Text format    


  85. TONG Y, Lu Q, Zhang Y, Zhan F, et al
    Association of functional genetic variants in PPARgamma and PPARalpha encoding peroxisome proliferator-activated receptors with ischemic stroke in a unique Chinese population.
    Int J Cardiol. 2015;190:205-7.
    PubMed     Text format    


  86. ACAMPA M, Guideri F, Tassi R, Dello Buono D, et al
    P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism?
    Int J Cardiol. 2015;190:202-4.
    PubMed     Text format    


    June 2015
  87. LAI HC, Chien WC, Chung CH, Lee WL, et al
    Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of traffic accidents: A population-based cohort study.
    Int J Cardiol. 2015;197:133-139.
    PubMed     Text format     Abstract available


  88. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Response to "Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality".
    Int J Cardiol. 2015;189:247-8.
    PubMed     Text format    


  89. AGARWAL S, Parashar A, Kumbhani DJ, Svensson LG, et al
    Comparative meta-analysis of balloon-expandable and self-expandable valves for transcatheter aortic valve replacement.
    Int J Cardiol. 2015;197:87-97.
    PubMed     Text format     Abstract available


  90. LASEK-BAL A, Gasior Z, Kowalewska-Twardela T, Urbanek T, et al
    New-onset atrial fibrillation in patients with elevated troponin I levels in the acute phase of stroke.
    Int J Cardiol. 2015;195:210-211.
    PubMed     Text format    


    May 2015
  91. CHEN JJ, Lin LY, Yang YH, Hwang JJ, et al
    Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?
    Int J Cardiol. 2015;196:53.
    PubMed     Text format    


  92. BRAMBATTI M, Darius H, Oldgren J, Clemens A, et al
    Comparison of dabigatran versus warfarin in diabetic patients with atrial fibrillation: Results from the RE-LY trial.
    Int J Cardiol. 2015;196:127-131.
    PubMed     Text format     Abstract available


  93. XIONG Q, Chen S, Senoo K, Proietti M, et al
    The CHADS and CHADS-VASc scores for predicting ischemic stroke among East Asian patients with atrial fibrillation: A systemic review and meta-analysis.
    Int J Cardiol. 2015;195:237-242.
    PubMed     Text format     Abstract available


  94. LOSI MA, Izzo R, Stabile E, Sannino A, et al
    Diastolic dysfunction reduces stroke volume during daily's life activities in patients with severe aortic stenosis.
    Int J Cardiol. 2015;195:64-65.
    PubMed     Text format    


  95. POTLURI R, Wasim M, Markandey B, Kapour A, et al
    Length of hospital stay is shorter in South Asian patients with ischaemic stroke.
    Int J Cardiol. 2015;187:190-1.
    PubMed     Text format    


  96. WONG K, Sze S, Wong S, McSwiggan S, et al
    Myocardial fibrosis in stroke survivors.
    Int J Cardiol. 2015;187:138-40.
    PubMed     Text format    


  97. HURLEY C, Dai S, Sobieraj DM
    The impact of inpatient rivaroxaban versus warfarin on hospital-based outcomes when used for stroke prevention in patients with anticoagulant naive, new-onset nonvalvular atrial fibrillation.
    Int J Cardiol. 2015;192:1-2.
    PubMed     Text format    


    April 2015
  98. STERLING LH, Windle SB, Filion KB, Eisenberg MJ, et al
    Pharmacological management strategies for stroke prevention following transcatheter aortic valve replacement: A systematic review.
    Int J Cardiol. 2015;191:303-311.
    PubMed     Text format     Abstract available


  99. HSU CW, Huang YB, Chen CY
    Effect of antithrombotic and antiplatelet agents for ischemic stroke in atrial fibrillation patients with dialysis.
    Int J Cardiol. 2015;190:349.
    PubMed     Text format    


  100. LI M, Li K, Zhang XW, Hou WS, et al
    Habitual snoring and risk of stroke: A meta-analysis of prospective studies.
    Int J Cardiol. 2015;185:46-9.
    PubMed     Text format    


  101. WANG J, Gu C, Gao M, Yu W, et al
    Comparison of the incidence of postoperative neurologic complications after on-pump versus off-pump coronary artery bypass grafting in high-risk patients: A meta-analysis of 11 studies.
    Int J Cardiol. 2015;185:195-7.
    PubMed     Text format    


  102. MOSCHONAS IC, Goudevenos JA, Tselepis AD
    Protease-activated receptor-1 antagonists in long-term antiplatelet therapy. Current state of evidence and future perspectives.
    Int J Cardiol. 2015;185:9-18.
    PubMed     Text format     Abstract available


  103. VAN DOORN S, Hartman-Weide F, Geersing GJ, Oudega R, et al
    Reasons for non-adherence to practice guidelines on stroke prevention in patients with atrial fibrillation: A cross-sectional study in primary care.
    Int J Cardiol. 2015;187:525-526.
    PubMed     Text format    


  104. YILDIZ A, Soydinc S
    Digoxin or digoxin prescribed patient? Randomized trials are essential to discriminate the principal risk factor for the association of digoxin and increased mortality.
    Int J Cardiol. 2015;184:512-3.
    PubMed     Text format    


  105. FINSTERER J, Zarrouk-Mahjoub S
    Management of juvenile stroke from noncompaction with muscular dystrophy.
    Int J Cardiol. 2015;184:371-2.
    PubMed     Text format    


  106. LI M, Zhang Z, Chen Y
    A comparison of stroke and coronary risks in Chinese and American.
    Int J Cardiol. 2015;184:251-3.
    PubMed     Text format    


  107. ZHANG E, Liu T, Li Z, Zhao J, et al
    High CHA2DS2-VASc score predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography.
    Int J Cardiol. 2015;184:540-2.
    PubMed     Text format    


  108. CARLSSON AC, Wandell P, Gasevic D, Sundquist J, et al
    Neighborhood deprivation and warfarin, aspirin and statin prescription - A cohort study of men and women treated for atrial fibrillation in Swedish primary care.
    Int J Cardiol. 2015;187:547-552.
    PubMed     Text format     Abstract available


    March 2015
  109. RUNEV NM, Dimitrov SM
    Management of stroke prevention in Bulgarian patients with non-valvular atrial fibrillation (BUL-AF Survey).
    Int J Cardiol. 2015;187:683-685.
    PubMed     Text format    


  110. CHEN CH, Chen MC, Gibbs H, Kwon SU, et al
    Antithrombotic treatment for stroke prevention in atrial fibrillation: The Asian agenda.
    Int J Cardiol. 2015;191:244-253.
    PubMed     Text format     Abstract available


  111. NAIROOZ R, Sardar P, Pino M, Aronow WS, et al
    Meta-analysis of risk of stroke and thrombo-embolism with rivaroxaban versus vitamin K antagonists in ablation and cardioversion of atrial fibrillation.
    Int J Cardiol. 2015;187:345-353.
    PubMed     Text format     Abstract available


  112. LIN HJ, Chen ST, Wu HY, Hsu HC, et al
    Urinary biomarkers of oxidative and nitrosative stress and the risk for incident stroke: a nested case-control study from a community-based cohort.
    Int J Cardiol. 2015;183:214-20.
    PubMed     Text format     Abstract available


  113. O'NEAL WT, Tanner RM, Efird JT, Baber U, et al
    Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
    Int J Cardiol. 2015;185:219-223.
    PubMed     Text format     Abstract available


  114. DENTALI F, Botto GL, Gianni M, Ambrosino P, et al
    Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature.
    Int J Cardiol. 2015;185:72-77.
    PubMed     Text format     Abstract available


  115. WONG CX, Lee SW, Gan SW, Mahajan R, et al
    Underuse and overuse of anticoagulation for atrial fibrillation: A study in Indigenous and non-Indigenous Australians.
    Int J Cardiol. 2015;191:20-24.
    PubMed     Text format     Abstract available


  116. MCCALL SJ, Musgrave SD, Potter JF, Hale R, et al
    The shock index predicts acute mortality outcomes in stroke.
    Int J Cardiol. 2015;182:523-7.
    PubMed     Text format     Abstract available


  117. WANG J, Gu C, Gao M, Yu W, et al
    Adjunct coronary endarterectomy increases cerebrovascular accident after coronary artery bypass grafting: a meta-analysis of 17,600 patients.
    Int J Cardiol. 2015;182:79-81.
    PubMed     Text format    


    February 2015
  118. SZYMANSKI FM, Platek AE, Filipiak KJ
    Is obstructive sleep apnea associated with the risk of ischemic stroke in patients with atrial fibrillation?
    Int J Cardiol. 2015;184:481-482.
    PubMed     Text format    


  119. KALEMCI S, Altun I, Akin F, Biteker M, et al
    Obstructive sleep apnea and stroke risk in atrial fibrillation: Is there a correlation or not?
    Int J Cardiol. 2015;184C:306.
    PubMed     Text format    


  120. NOWAK R, Jaguszewski M, Fijalkowski M, Fijalkowska M, et al
    CMR to distinguish Takotsubo cardiomyopathy from myocardial infarction in acute course of ischemic stroke in a male patient.
    Int J Cardiol. 2015;184C:397-398.
    PubMed     Text format    


  121. SENOO K, Lane DA, Lip GY
    Stroke risk reduction with oral anticoagulation using CHA2DS2-VASc in a Japanese AF population: A modeling analysis.
    Int J Cardiol. 2015;181:247-54.
    PubMed     Text format     Abstract available


  122. KRAL M, Sanak D, Veverka T, Hutyra M, et al
    Troponin T: Correlation with location and volume of acute brain infarction.
    Int J Cardiol. 2015;181:127-32.
    PubMed     Text format     Abstract available


    January 2015
  123. RAPOSEIRAS-ROUBIN S, Garcia-Seara J, Cabanas-Grandio P, Abu-Assi E, et al
    Is safe to discontinue anticoagulation after successful ablation of atrial flutter?
    Int J Cardiol. 2015;201:631-632.
    PubMed     Text format    


  124. WINKEL P, Hilden J, Hansen JF, Kastrup J, et al
    Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial.
    Int J Cardiol. 2015;182C:459-465.
    PubMed     Text format     Abstract available


  125. MENON J, Vijayakumar N, Joseph JK, David PC, et al
    Below the poverty line and non-communicable diseases in Kerala: The Epidemiology of Non-communicable Diseases in Rural Areas (ENDIRA) study.
    Int J Cardiol. 2015;187:519-24.
    PubMed     Text format     Abstract available


    December 2014
  126. CHANG CC, Chiu CC, Chiang CH, Huang CC, et al
    Obstructive sleep apnea and the risk of ischemic stroke in patients with atrial fibrillation.
    Int J Cardiol. 2014;181C:144-146.
    PubMed     Text format    


    November 2014
  127. LIP GY, Wang KL, Chiang CE
    Non-vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in Asian patients with atrial fibrillation: Time for a reappraisal.
    Int J Cardiol. 2014;180C:246-254.
    PubMed     Text format     Abstract available


  128. PASTORI D, Farcomeni A, Bucci T, Cangemi R, et al
    Digoxin treatment is associated with increased total and cardiovascular mortality in anticoagulated patients with atrial fibrillation.
    Int J Cardiol. 2014;180C:1-5.
    PubMed     Text format     Abstract available


  129. YEH PS, Yang CM, Lin SH, Wang WM, et al
    Antithrombotic therapy for atrial fibrillation in patients with acute ischemic stroke or transient ischemic attack.
    Int J Cardiol. 2014;179C:288-291.
    PubMed     Text format    


  130. KORNEJ J, Lobe S, Efimova E, Husser D, et al
    NT-proBNP in "low risk" patients with atrial fibrillation.
    Int J Cardiol. 2014 Nov 6. pii: S0167-5273(14)02188.
    PubMed     Text format    


    October 2014
  131. VASSILIOU V, Rana B, Goddard M, Braganza D, et al
    Acute myocardial infarction and acute stroke: Between a rock and a hard place.
    Int J Cardiol. 2014;180C:214-215.
    PubMed     Text format    


  132. CHEN JJ, Lin LY, Yang YH, Hwang JJ, et al
    Anti-platelet or anti-coagulant agent for the prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation-A nation-wide database analyses.
    Int J Cardiol. 2014;177:1008-1011.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: